WANBURY
Back to Cashflow Statement
|
WANBURY Last 5 Year Net Cash Inflow / Outflow History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Cash Inflow / Outflow | ₹0.66 Cr | ₹1.94 Cr | ₹-21 Cr | ₹13 Cr | ₹7.34 Cr |
What is the latest Net Cash Inflow / Outflow ratio of WANBURY ?
| Year | Net Cash Inflow / Outflow |
|---|---|
| Mar2025 | ₹0.66 Cr |
| Mar2024 | ₹1.94 Cr |
| Mar2023 | ₹-21 Cr |
| Mar2022 | ₹13 Cr |
| Mar2021 | ₹7.34 Cr |
How is Net Cash Inflow / Outflow of WANBURY Trending?
| Years | Net Cash Inflow / Outflow | % Change | |
|---|---|---|---|
| Mar2025 | ₹0.66 Cr | -66.07 | |
| Mar2024 | ₹1.94 Cr | Positive | |
| Mar2023 | ₹-21 Cr | Negative | |
| Mar2022 | ₹13 Cr | 70.64 | |
| Mar2021 | ₹7.34 Cr | - | |
Compare Net Cash Inflow / Outflow of peers of WANBURY
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| WANBURY | ₹867.3 Cr | -3.5% | -1.4% | 21.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹426,782.0 Cr | -2.5% | 4.7% | 7.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹163,125.0 Cr | -2.1% | -0.2% | 7.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹145,252.0 Cr | -3.4% | 0.7% | 39.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹108,025.0 Cr | -1.9% | 2% | 16.1% | Stock Analytics | |
| CIPLA | ₹102,443.0 Cr | -4.3% | -6.5% | -11.9% | Stock Analytics | |
WANBURY Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| WANBURY | -3.5% |
-1.4% |
21.8% |
| SENSEX | -0.2% |
-7.2% |
3.5% |
You may also like the below Video Courses